Cyprus vs Egypt: Share of S. aureus infections resistant to methicillin
Cyprus
55.9%
in 2022
Egypt
69.4%
in 2022
Cyprus rank
5th
Egypt rank
2nd
Share of S. aureus infections resistant to methicillin over time
- Cyprus
- Egypt
How they compare
Egypt currently reports 69.4% against 55.9% in Cyprus, a difference of 13.5%.
That makes Egypt's figure about 1.2 times Cyprus's.
The two have swapped places 2 times across 5 shared years of data; in 2018 it was Egypt ahead.
Cyprus ranks 5th and Egypt ranks 2nd of 45 countries.
Egypt has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 70.1% | 75.0% | 4.9% | Egypt |
| 2020s | 49.5% | 87.2% | 37.8% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Cyprus or Egypt?
- Egypt, at 69.4% against 55.9% in Cyprus as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Cyprus and Egypt?
- 13.5%, with Egypt ahead.
- How many years of comparable data are there for Cyprus and Egypt?
- 5 years are reported by both, from 2018 to 2022.
- How do Cyprus and Egypt rank globally for share of s. aureus infections resistant to methicillin?
- Cyprus ranks 5th and Egypt ranks 2nd of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).